Nivalis Therapeutics, Inc.
SEC CIK 1626199 · NVLS · last insider filing 2024-05-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Orbimed Advisors LLC | Director | filed 2017 - 2024 |
| Conway Robert E | Director | filed 2015 - 2024 |
| Gold Mitchell | Director · Executive Chairman and CEO | filed 2017 - 2024 |
| Topper James N | Director | filed 2017 - 2024 |
| Thompson Peter A. | Director | filed 2017 - 2024 |
| Cui Xiangmin | Director | filed 2019 - 2024 |
| Peetz Christopher | Director | filed 2018 - 2024 |
| Orbimed Capital GP VI LLC | Director | filed 2017 - 2024 |
| Hernday Natasha | Director | filed 2020 - 2024 |
| Drappa Jorn | Director | filed 2022 - 2024 |
| Orbimed Genesis GP LLC | Director | filed 2021 - 2024 |
| Venkatesan Jay | Director · President | filed 2017 - 2022 |
| Sekhri Paul J | Director | filed 2016 - 2020 |
| Isaly Samuel D | Director | filed 2017 - 2017 |
| Smith Cynthia | Director | filed 2016 - 2016 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2015 - 2016 |
| Moore John R | Director | filed 2015 - 2016 |
| Flynn James E | Director | filed 2015 - 2016 |
| Furst Howard P. | Director | filed 2015 - 2016 |
| Loh Evan | Director | filed 2015 - 2016 |
| Congleton Jon | Director · President and CEO | filed 2015 - 2016 |
| Leff Jonathan S | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Rickey James Paul | Senior VP and CFO | filed 2017 - 2024 |
| Peng Stanford L | See Remarks | filed 2017 - 2024 |
| Durand Remy | Chief Business Officer | filed 2023 - 2024 |
| Fuhs Ulrich Martin | Chief Accounting Officer | filed 2024 - 2024 |
| Dummer Wolfgang | Chief Medical Officer | filed 2023 - 2023 |
| Sandler Andrew Seth | Chief Medical Officer | filed 2022 - 2023 |
| Goldberg Zelanna | Chief Medical Officer | filed 2021 - 2021 |
| Litton Mark James | See Remarks | filed 2018 - 2019 |
| Troha Janice | Executive VP & COO | filed 2015 - 2017 |
| Carruthers R Michael | Interim President / CFO | filed 2015 - 2017 |
| Rodman David Malcom | See Remarks | filed 2016 - 2017 |
| Shoemaker Steven | VP of Clinical R & D & Med Dir | filed 2015 - 2015 |
| Gabriel Sherif | Vice President Research | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.